A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc patents ...
The ruling from U.S. District Judge Richard Andrews in Wilmington, Delaware was the latest reversal of fortune in a long-running lawsuit in which Amgen is seeking to stop French drugmaker Sanofi and U.S. biotech Regeneron from selling their drug Praluent.
The judge, in setting aside the jury’s verdict reached in February, said some patent claims by Amgen relating to antibodies targeting PCSK9 were invalid because they did not sufficiently disclose the Thousand Oaks, California-based company’s claimed innovations. California-based Amgen said in a statement that it disagreed with aspects of the court’s decision and will seek review by the appellate court.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
It Is Too Early for Pharma Investors to Cheer Opioid VerdictHold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon, despite an Oklahoma judge’s ruling that Johnson & Johnson is liable for fueling the opioid crisis.
Leer más »
Factbox: Oklahoma judge finds J&J liable in first trial over opioidsAn Oklahoma judge on Monday ruled that Johnson & Johnson was liable for its part...
Leer más »
Missouri ban on abortion after eight weeks temporarily blocked by U.S. judgeA U.S. federal judge on Tuesday blocked Missouri from enforcing a law banning ab...
Leer más »
Facebook tightens rules for U.S. political advertisers ahead of 2020 electionFacebook Inc is tightening its political ad rules in the United States, it said ...
Leer más »